Ji Pharma, a biopharmaceutical company specializing in innovative CAR-T cell therapy, has announced its 2026 interim performance. As of June...
-
-
Recent Updates
- Unitree’s Shanghai Debut Rockets Over 600%
- Unitree, Chinese Humanoid Robot Maker, Sees 629% Surge in Shanghai Debut
- China Emerges as Global Leader in Robotics Training Amid AI Revolution
- Chinese Technology Stocks Slide Amid Semiconductor and Robotics Sell-Off
- Unitree’s Remarkable IPO Success in China’s Robotics Sector
- Unitree’s Shanghai Debut Signals Boom in China’s Robotics Sector
- China’s Rural Data Centers Revolutionizing AI Power
- China’s Arctic Ambitions: The Race for the Ice Silk Road
- China’s AI Industry Thriving Across Diverse Regions
- Ji Pharma Releases 2026 Interim Performance
Blogroll